Strangles Flashcards

1
Q

What are the initial signs of the disease in horses?

A

Abrupt pyrexia (sudden onset of fever), pharyngitis (inflammation of the pharynx), and abscess formation commonly in submandibular and retropharyngeal lymph nodes.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Which age group of horses is most susceptible to the disease?

A

Horses aged 6-10 years are most commonly affected based on surveillance via qPCR.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

How does the disease severity vary with the age of the horse?

A

Younger horses exhibit more severe signs, while older horses are less affected and recover faster.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What factors influence the variability in the presentation of the disease?

A

The immune status of the horse and the fact that not all horses show classic signs.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

When do the first signs of the disease typically appear post-exposure?

A

First signs usually include fever and lethargy occurring 3-14 days post-exposure.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

How severe can the fever get in horses with this disease?

A

Fever can be severe, exceeding 42°C (107.6°F), and may persist until abscess rupture.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What are the accompanying symptoms of significant pharyngitis in horses?

A

Reluctance to eat or drink, abnormal head positions due to pain, nasal discharge, and a soft, mucoid cough often associated with eating.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What signs indicate laryngeal pain in horses?

A

Pain on squeezing the larynx causing stridor, gagging, and coughing.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Which lymph nodes are commonly affected by the disease?

A

Submandibular and retropharyngeal lymph nodes, occasionally parotid and cranial cervical.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Describe the development and rupture of abscesses in horses.

A

Abscesses develop a thick fibrous capsule and rupture in 7 days to 4 weeks. Initial signs include warm, diffuse swelling, serum oozing from the skin before rupture, and thick purulent discharge either externally or internally.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What are the signs of empyema of the guttural pouch in horses?

A

Expulsion of discharge with coughing or eating, and intermittent unilateral nasal discharge and cough in approximately 50% of cases.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What neurological impacts can occur due to this disease?

A

Neuropraxia causing temporary laryngeal hemiplegia or dysphagia, damage to the recurrent laryngeal nerve, paralysis of arytenoid cartilage, and dysphagia with potential reflux of feed or water from nares.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What is “bastard strangles” and what sites can it affect?

A

Abscesses in multiple sites including the brain, abdomen, and mammary gland; it is a term used for metastatic abscesses.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

How does S. equi enter and attach to the host cells?

A

S. equi enters through the mouth or nose, attaching to cells within the crypts of the lingual and palatine tonsils and the follicular-associated epithelium of the pharyngeal and tubal tonsils. Initial binding is facilitated by exposed surface proteins such as SzPSe.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What happens within a few hours after S. equi penetrates the host cells?

A

The organism penetrates and becomes difficult to detect on the mucosal surface but is visible within epithelial cells and subepithelial tonsillar follicles. Note that nasal or NP samples may be culture negative in the early stages of infection.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What occurs during the early stages of S. equi infection?

A

Translocation to mandibular and retropharyngeal lymph nodes occurs within hours, involving complement-derived chemotactic factors attracting polymorphonuclear neutrophils. Abscess formation is not grossly evident for 3-5 days post-infection.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

What mechanisms does S. equi use to evade phagocytosis?

A

Neutrophils fail to phagocytose and kill S. equi due to hyaluronic acid capsule, antiphagocytic SeM protein, H factor binding Se18.9, Mac protein, and other undetermined factors.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

How is effective bacterial disposal achieved in S. equi infection?

A

Effective bacterial disposal relies on the lysis of the abscess capsule and evacuation of its contents.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

When does nasal shedding of S. equi begin and how long does it last?

A

Nasal shedding begins 2-3 days after fever onset, lasting 2-3 weeks in most horses. Some horses with preexisting immunity may not exhibit detectable shedding, and persistent shedding can occur if infection persists in the guttural pouch or sinus.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

What are the characteristics of immune responses to S. equi infection?

A

Systemic and mucosal immune responses develop 2-3 weeks post-infection, coinciding with mucosal clearance. Natural exposure and infection boost immunity and contribute to herd immunity, with 75% of horses developing long-term immunity without antibiotic treatment.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

What is the infectious dose of S. equi in natural transmission?

A

The infectious dose in natural transmission is lower than in propagated media, as virulence factors are better expressed in vivo. Inocula of less than 10^6 colony-forming units are often insufficient to cause disease due to effective mucociliary clearance.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

What is convalescent immunity and how effective is it in horses recovering from S. equi infection?

A

Horses develop resistance to high experimental challenges during the convalescent phase. However, 20-25% may be susceptible to reinfection within months, indicating inadequate mucosal and systemic antibody maintenance. Approximately 75% develop long-term immunity.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

What are catarrhal or atypical strangles, and how do they affect horses?

A

Older horses with residual immunity, foals with waning maternal antibodies, and vaccinated horses exhibit milder forms of strangles but still shed virulent S. equi. These horses still shed virulent S. equi and can induce severe disease in naïve individuals.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

How do mares provide passive immunity to their foals?

A

Milk from mares recovering from strangles contains IgGb and IgA, providing passive immunity to suckling foals. Colostral antibodies ingested in the first 24 hours recirculate to the nasopharyngeal mucosa, offering additional protection.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

What is the timing of shedding for S. equi and its implications for isolation?

A

Shedding typically starts 1-2 days after fever onset, allowing potential isolation before transmission. Nasal shedding lasts 2-3 weeks, with infectious potential up to 6 weeks after discharges cease. Persistent guttural pouch infections may shed intermittently for years.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
26
Q

How is the severity of S. equi disease linked to infectious exposure?

A

The severity of the disease is linked to the dose and frequency of infectious exposure. ​

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
27
Q

What are the primary sources of S. equi infections in active and recovering horses?

A

Horses with active or recovering strangles due to purulent discharges from lymph nodes, nose, and eyes.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
28
Q

How does direct transmission of S. equi occur?

A

Through direct horse-to-horse contact and normal equine social behaviors such as head-to-head or nose-to-nose interactions.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
29
Q

What are some methods of indirect transmission of S. equi?

A

Sharing contaminated housing, water sources, feed, or feeding utensils, and the use of shared twitches, tack, and other equipment. Less obvious fomites like the clothing and equipment of handlers and veterinarians can also be sources. Anecdotal evidence suggests transmission via other animal species is possible.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
30
Q

Why are healthy carriers significant in the spread of S. equi?

A

Healthy-appearing animals can significantly spread S. equi, especially in initiating new outbreaks or recurrences in previously affected herds.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
31
Q

What is the role of horses incubating S. equi disease in transmission?

A

Some horses that are incubating the disease may appear outwardly healthy and infectious. These horses eventually develop signs of strangles, and their nasal secretions are assumed to be the source of infection.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
32
Q

What defines convalescent carriers of S. equi?

A

Outwardly healthy horses that have fully recovered may continue to harbor the organism. These horses can remain infectious for at least 6 weeks after purulent discharges have dried up. Periodic shedding of S. equi can occur for prolonged periods after apparent full recovery. These horses are referred to as long-term, subclinical carriers and can be a source of new or recurrent disease in well-managed groups of horses.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
33
Q

How long can recovered horses remain infectious after purulent discharge clearance?

A

Recovered horses can be infectious for at least 6 weeks post-discharge clearance.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
34
Q

What is necessary for the effective control of long-term carriers?

A

Detection, segregation, and treatment of these carrier animals.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
35
Q

What characterizes most outbreaks of S. equi?

A

Most outbreaks are highly clonal, indicating transmission from a single source. Both active and persistent carriage strains can be identified in chondroids (hardened pus) from horses in the same stable. Genomic analysis of isolates from various large outbreaks shows evidence for the persistence of S. equi, leading to new clinical cases.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
36
Q

How long can S. equi remain viable in water?

A

S. equi remains viable in water for 4-6 weeks.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
37
Q

How does S. equi survive in feces or soil under real-world conditions?

A

It does not survive well in feces or soil under real-world conditions.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
38
Q

What is the observed survival time of S. equi on fencing and soil?

A

Rapid death (1-3 days) on fencing and soil when in direct sunlight observed in recent studies.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
39
Q

What environmental factors affect the survival of S. equi?

A

S. equi is sensitive to bacteriocins from environmental bacteria and does not survive well in the presence of other soil-borne flora. ​

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
40
Q

What is the optimal sample for confirming S. equi infection?

A

A needle aspirate from an enlarged or abscessed lymph node.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
41
Q

How effective are nasopharyngeal swabs for detecting S. equi?

A

Nasopharyngeal swabs are useful but may miss early infection due to rapid bacterial invasion of lymph nodes and intermittent shedding.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
42
Q

Why are nasopharyngeal and guttural pouch washes preferred?

A

They are more sensitive than swabs, especially in detecting persistent infections, and are indicated for subclinical carriers.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
43
Q

Describe the procedure for nasopharyngeal washes.

A

Instil 50 mL of warm normal saline via soft latex tubing or uterine pipette to the level of the nasal canthus, collect the washings into a disposable cup or rectal sleeve, then centrifuge and test the pellet.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
44
Q

What is involved in guttural pouch sampling?

A

Introduce 50 mL of warm saline via polyethylene tubing using the instrument channel of an endoscope. Blind sampling with a stiff, bent catheter can also be performed, but these washings are not necessarily specific to the guttural pouches.

45
Q

What are the limitations of culture in detecting S. equi?

A

Sensitivity is reduced during incubation, early clinical phases, and low bacterial count during convalescence. Culture recovery can be as low as 40%, and S. equi is not usually present on mucosa until 24-48 hours after fever onset.

46
Q

Why is culture no longer considered the gold standard for S. equi detection?

A

The reduced sensitivity of culture has led most authors to conclude it is no longer the gold standard for S. equi detection.

47
Q

What is the advantage of qPCR over traditional culture methods?

A

qPCR is approximately 3 times more sensitive than culture, can detect both live and dead organisms, and can provide same-day results within 1-2 hours.

48
Q

What are the limitations and considerations of PCR testing for S. equi?

A

PCR does not distinguish between live and dead organisms, potentially leading to false positives. The presence of polymerase inhibitors or abundant S. equi may lead to negative PCR results even when culture is positive.

49
Q

What is the recommended use of PCR testing for detecting carrier animals?

A

It is recommended for use in detecting subclinically infected carrier animals via endoscopically guided guttural pouch lavage, accompanied by visual inspection of the guttural pouch.

50
Q

What are the pros and cons of aspirate of mature abscessed lymph nodes?

A

Pros: High yield of bacterial organisms.
Cons: Requires this stage of disease.

51
Q

What are the advantages of nasopharyngeal washes over nasopharyngeal swabs?

A

Nasopharyngeal washes sample more surface area and are found to be more sensitive than nasopharyngeal swabs.

52
Q

What are the target antigens for various proprietary ELISAs?

A

Total IgG antibodies against different S. equi surface proteins, including SeM and the combined Antigen A and Antigen C.

53
Q

What is the response time for SeM antibody titre?

A

Antibody titres peak about 5 weeks after exposure and remain high for at least 6 months.

54
Q

What are the purposes of SeM antibody titre?

A

Detection of recent infection, support for diagnosing purpura haemorrhagica and metastatic abscessation, and identification of animals at risk for purpura haemorrhagica.

55
Q

What are the advantages of the Combined Antigen A and C iELISA over the SeM antibody titre?

A

It offers greater specificity by targeting unique fragments and can identify recent infection as early as 2 weeks post-exposure, detect exposed but asymptomatic carriers, and screen new arrivals for exposure or persistent infection.

56
Q

What is the purpose of post-outbreak identification using the Combined Antigen A and C iELISA and qPCR?

A

To identify subclinically infected persistent carriers at the end of an outbreak, with testing commencing no sooner than 3 weeks after resolution of the last clinical case. ​

57
Q

What type of vaccine is Strepvax II and what is its schedule?

A

Strepvax II is a purified M-protein antigen extract vaccine. Naïve horses require 3 doses at 3-week intervals, with annual booster doses. An additional booster at 6 months is recommended for foals vaccinated initially at less than 3 months of age. Pregnant mares may be boosted a month before foaling.

58
Q

What is the efficacy of Strepvax II?

A

It induces serum antibody responses in 7-10 days, but field studies show only a 50% reduction in clinical attack rate.

59
Q

What are the adverse reactions to Strepvax II?

A

Soreness or abscesses at injection sites and occasional cases of purpura haemorrhagica.

60
Q

Describe the Pinnacle IN vaccine and its schedule.

A

Pinnacle IN is an intranasal live vaccine administered in 2 doses at 2-3 week intervals, with annual booster doses.

61
Q

What are the application guidelines and safety issues for Pinnacle IN?

A

Administer only to healthy, non-febrile animals free of nasal discharge, ensuring adequate vaccine reaches the pharyngeal and lingual tonsils. Safety issues include residual virulence, causing mandibular abscesses in some vaccinates, nasal discharge, immune-mediated vasculitis (purpura), risk of abscess formation at remote injection sites, and not for use in foals under 1 year of age.

62
Q

What are the contraindications and outbreak use recommendations for Pinnacle IN?

A

Not for horses with recent strangles or within a year of an outbreak, and avoid vaccinating horses with high S. equi-specific serum antibody levels (≥1:3,200) due to the risk of purpura haemorrhagica. It is not recommended during outbreaks except for horses with no known contact with infected animals.

63
Q

What is Equilis StrepE and how is it administered?

A

Equilis StrepE is a live attenuated aroA deletion mutant administered submucosally on the inside of the upper lip.

64
Q

What is the duration of immunity and safety issues for Equilis StrepE?

A

The immunity duration is about 3 months post-vaccination. Safety issues include no DIVA capability, painful reactions at injection sites, rare cases of clinical disease from vaccine strain replication, and incidents of accidental veterinarian self-injection.

65
Q

What is Strangvac and what do challenge studies show?

A

Strangvac is a multicomponent vaccine in development in Sweden with DIVA capability. Challenge studies show a significant reduction in disease severity after an initial series of 2 intramuscular injections, with continued protection from a booster given 3 months after the initial series.

66
Q

What were the results of Strangvac prototype tests?

A

Demonstrated significant reduction in disease severity 2 weeks and 2 months post-vaccination.

67
Q

What do genomic studies reveal about S. equi strains?

A

Identified 3 major groups of S. equi strains, with currently circulating strains in the UK being genetically distant from available live attenuated vaccine strains, suggesting the need for studies to determine cross-protection efficacy of existing vaccines against current strains.

68
Q

What is known about passive immunity through maternal antibodies?

A

Transfer mainly involves IgGb antibodies in serum and nasal secretions. Prepartum extract vaccination increases colostral IgGb and IgA levels. Foals from vaccinated mares have higher SeM-specific IgGb titers, but not IgA, in mucosal washes. Resistance to strangles in foals appears mediated by IgGb in mucosal secretions and milk.

69
Q

What are the current consensus and limitations regarding strangles vaccines?

A

Vaccine use varies by region, and there are differences in efficacy and experiences with vaccines. Current vaccines have limited proven efficacy and DIVA capabilities with the latest diagnostic assays. ​

70
Q

What is the key strategy to prevent S. equi infections?

A

Limiting exposure through quarantine and screening.

71
Q

What are the biosecurity measures for quarantining new arrivals?

A

Isolate new horses for at least 3 weeks, which can be challenging on farms with frequent horse movement.

72
Q

How is screening for subclinical carriers conducted?

A

Guttural pouch endoscopy for direct visual assessment, culture and PCR testing to detect carriers, and combined SEQ_2190 and SeM serology tests for unvaccinated horses in certain regions.

73
Q

What are the recommended disinfection and cleaning practices?

A

Clean potentially contagious equipment thoroughly and use appropriate disinfectants.

74
Q

What initial steps should be taken to control an outbreak of S. equi?

A

Collect detailed history from horse owners, stable managers, and caretakers, including travel history, management practices, and vaccine history. Evaluate the facility and develop a logical and practical plan.

75
Q

What are the primary objectives in controlling an outbreak?

A

Identify and segregate infected horses, prevent further spread of infection, identify subclinical carriers of S. equi, and ensure compliance with local laws on reporting and movement restrictions.

76
Q

What is the prevalence of persistent guttural pouch empyema in strangles outbreaks?

A

About 10% of horses in strangles outbreaks experience persistent guttural pouch empyema, with a retrospective study showing 40% of cases 40 days post-diagnosis were positive by culture or PCR.

77
Q

What are the pathology characteristics of persistent guttural pouch empyema?

A

Persistent pathology may last for months or years, with pus in pouches forming chondroids that harbor viable S. equi.

78
Q

What detection methods are used for guttural pouch empyema?

A

Endoscopy for direct visual assessment, radiography for diagnosing empyema with or without chondroids, and combined culture and PCR testing of lavage samples collected via endoscope.

79
Q

What is the recommended treatment approach for guttural pouch carriers?

A

Identifying, treating, and eliminating guttural pouch carriers is effective in eradicating infection in a herd.

80
Q

What are the general methods for treating guttural pouch carriers?

A

Repeated lavage using isotonic saline or polyionic fluid, sedation to facilitate endoscopy and drainage, and the use of suction pumps attached to endoscopes.

81
Q

Describe the lavage technique for treating guttural pouch carriers.

A

Rinse pus-filled pouches using rigid or indwelling catheters, lower the horse’s head to allow drainage or use suction pumps, and sedation aids in implementation and drainage.

82
Q

What is the function of acetylcysteine installation in guttural pouch treatment?

A

It denatures and solubilizes mucoprotein molecules, reducing mucus viscosity.

83
Q

What non-surgical options are available for removing chondroids?

A

Memory-helical polyp retrieval basket used through the endoscope biopsy channel and effective removal of chondroids even in large numbers.

84
Q

What surgical options are available for treating guttural pouch lesions?

A

Hyovertebrotomy and ventral drainage through Viborg’s triangle, which involves general anesthesia and surgical dissection around major blood vessels and nerves.

85
Q

What are the challenges and treatments for scar tissue management in guttural pouch lesions?

A

Scarring may preclude natural drainage and endoscopic access. Treatments include conventional surgery or endoscopically guided laser treatments to break down scar tissue for pouch access. ​

86
Q

What is the primary objective of biosecurity measures during strangles outbreaks?

A

To prevent indirect transfer of S. equi from infectious horses (including potential subclinical carriers) to susceptible animals.

87
Q

What are the steps involved in cleaning and disinfection during a strangles outbreak?

A

Initial cleaning with foaming soap agents to remove organic material, thorough rinsing to remove soap and organic residues, soaking surfaces in an appropriate liquid disinfectant, and allowing surfaces to dry completely while avoiding high-pressure systems to prevent aerosolization of bacteria.

88
Q

What considerations are there for disinfecting wooden surfaces?

A

Wooden surfaces require adequate drying time before treatment with paint or creosote, and replacement with new or alternative material may be more effective.

89
Q

PasHow should pastures be managed after removing infectious animals?

A

Pastures should be rested for several weeks to allow for S. equi denaturation. Drying and direct sunlight are effective, especially during hot dry weather, and cultured S. equi survives less than 24 hours on wood, rubber, and metal surfaces in direct sunlight.

90
Q

What measures should be taken for horse vans and stalls?

A

Clean and disinfect horse vans after each use, and hold stalls open after cleaning/disinfection for adequate contact time with disinfectant and thorough drying.

91
Q

How effective are Streptococcus spp. against disinfection?

A

Streptococcus spp., including S. equi, are relatively susceptible to disinfection.

92
Q

What considerations should be made when using disinfectants?

A

Ensure thorough cleaning of surfaces to remove organic material before using disinfectants, and note that diluted bleach and foot baths become quickly inactivated when contaminated by organic debris.

93
Q

How common are human infections with S. equi and who is at risk?

A

Human infections are rare but reported in debilitated humans, as S. equi is highly host-adapted to horses.

94
Q

What precautions should animal handlers take during a strangles outbreak?

A

Avoid unnecessary contamination from infectious horses, prevent respiratory and oral exposure to purulent material, and take special care for veterinary practitioners, pathologists, and equine post mortem attendants. ​

95
Q

What are the key aspects of rest and care for horses with strangles?

A

Ensure the horse has adequate rest in a dry and warm stall, provide soft, moist, and palatable food of good quality, ensure food and water are easily accessible to prevent dehydration and encourage feeding, and use fan-assisted ventilation in high temperatures.

96
Q

What are the main concerns regarding the use of antibiotics for treating strangles?

A

Delay in abscess maturation, recurrence of abscesses when antibiotics are discontinued, potential inhibition of protective antigen synthesis affecting immune response, and no conclusive data on antibiotics increasing the risk of metastatic abscesses (bastard strangles).

97
Q

When are antibiotics indicated for treating strangles?

A

In acute cases with very high fever and malaise before abscess formation, severe lymphadenopathy and respiratory distress, metastatic abscessation, purpura haemorrhagica (with corticosteroids), and guttural pouch infections.

98
Q

Why should antibiotics not be used preventatively in animals exposed to S. equi?

A

It promotes antibiotic resistance, provides a false sense of security, and convalescent immune responses may not be adequately induced.

99
Q

What is the recommended treatment for horses with early clinical signs of strangles?

A

Immediate antibiotic therapy during the early acute phase of infection when fever and lethargy are present to be curative and prevent focal abscessation.

100
Q

What are the challenges of treating horses with early clinical signs of strangles with antibiotics?

A

Difficulty in determining the exact time and dose of natural infection, premature cessation of antibiotics can lead to prolonged disease, and ensuring good infection control and biosecurity to prevent re-exposure.

101
Q

How should horses with lymph node abscessation be treated?

A

Focus on enhancing maturation and drainage of abscesses, apply topical treatments like ichthammol or hot packs, surgical drainage if abscesses do not rupture spontaneously, daily flushing with povidone iodine solution, and use NSAIDs to reduce fever, pain, and inflammatory swelling.

102
Q

What are the drugs of choice for treating strangles and their dosages?

A

Penicillin: 22,000–44,000 iu/kg IM q12h or IV q6h. Trimethoprim-Sulfadiazine (TMS): 30 mg/kg PO q12h. Ceftiofur and other cephalosporins/macrolides may be used for long-term treatment and lower respiratory tract infections.

103
Q

What is the incidence of general complications in strangles?

A

Complication rate can be as high as 20%, with case fatality rates ranging from 0.9% to 9.7% depending on outbreak size and farm management practices.

104
Q

What is metastatic abscessation (bastard strangles) and where can it spread?

A

S. equi can infect any anatomical site, commonly spreading to the lung, mesentery, liver, spleen, kidneys, and brain.

105
Q

What are the risk factors and clinical signs of purpura haemorrhagica?

A

High serum antibody titres to S. equi antigens, exposure to or vaccination with S. equi. Clinical signs include subcutaneous oedema, petechiation and ecchymoses on mucous membranes, severe oedema, gastrointestinal and respiratory complications, and muscle soreness.

106
Q

How is purpura haemorrhagica treated and what is the prognosis?

A

Treated primarily with corticosteroids (dexamethasone), antibiotics if associated with active bacterial infection, NSAIDs, and supportive care. Prognosis can be serious, with a significant mortality rate.

107
Q

What types of myositis are associated with strangles and their characteristics?

A

Muscle infarctions due to immune-mediated vasculitis, rhabdomyolysis with acute myonecrosis associated with clinically evident strangles, and rhabdomyolysis with progressive atrophy identified in Quarter Horses with underlying polysaccharide storage myopathy.

108
Q

What are the other complications that can arise from S. equi infection?

A

Extension of infection to sinuses, anemia, agalactia, myocarditis, endocarditis, panophthalmitis, periorbital abscesses, ulcerative keratitis, paravertebral abscesses, meningitis, funiculitis, septic arthritis, and tenosynovitis.